[2492423-29-5] of the unlabelled compound.

Synonyms : EIDD-1931 5′-isopropylester-13C5; N4-Hydroxycytidine 5′-isopropylester-13C5; beta-D-N4-Hydroxycytidine 5′-isopropylester-13C5; EIDD 1931 prodrug-13C5; N4OHcyd ester-13C5; 4-N-HO-Cyd ester-13C5; EIDD-1931 prodrug-13C5; N4-OHcyd ester-13C5; (oh)4Cyd lester-13C5; NHC ester-13C5; EIDD-1931 5′-isopropylester-13C5; EIDD1931 5′-isopropylester-13C5; EIDD-2801-13C5; MK-4482-13C5

Applications : Molnupiravir-13C5 is a 13C-carbon labelled analog of Molnupiravir, which is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza.

References : Sheahan T. P.: et al.: Sci Transl Med.,12(541), Apr 29 2020; Toots M. et al.: Sci Transl Med.,11(515), Oct 23 2019.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.